Abstract
High-quality evidence to provide specific recommendations on the nature of clinical and imaging surveillance after radiotherapy for NSCLC is lacking. Risk-stratification models are needed to determine optimal follow-up. We present a radiomics model to predict overall survival (OS) 2 years post-treatment, using radiotherapy planning CTs and the gross tumour volume (GTV), contoured for radiotherapy purposes as the region of interest for feature extraction.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
